To date, some serum tumor biomarkers, including carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), and CA72-4, have been used in diagnosing GC in asymptomatic patients but the results are unsatisfied due to low sensitivity and low positive predictive value [4]. This evidence concerns the gene CEACAM5 and neoplasm.